These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 25155484)
1. Response to letter to the editors. Yao FY; Hameed B; Mehta N; Roberts JP Liver Transpl; 2014 Oct; 20(10):1285. PubMed ID: 25155484 [No Abstract] [Full Text] [Related]
2. Is there an ideal cutoff for α-fetoprotein as an exclusion criterion for liver transplantation? de Mattos AA; dos Santos Schraiber L; Zanotell ML; Cantisani G Liver Transpl; 2014 Oct; 20(10):1284. PubMed ID: 25044482 [No Abstract] [Full Text] [Related]
3. α-Fetoprotein and hepatocellular cancer recurrence: a paradigm of the chaos theory. Lai Q; Lerut J; Liver Transpl; 2014 Oct; 20(10):1283. PubMed ID: 25060782 [No Abstract] [Full Text] [Related]
4. Survivals after liver transplantation for hepatocellular carcinoma: Granular data for a better allocation process? Lai Q; Rossi M Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):374-375. PubMed ID: 29866607 [No Abstract] [Full Text] [Related]
5. Expanding transplant criteria for hepatocellular carcinoma: small steps down a long road. Sanchez W Hepatology; 2009 Mar; 49(3):724-5. PubMed ID: 19241486 [No Abstract] [Full Text] [Related]
6. Biologic markers as predictors for liver transplant outcome. Freeman RB Am J Transplant; 2010 Jan; 10(1):10-1. PubMed ID: 19951278 [No Abstract] [Full Text] [Related]
7. Editorial on "a revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor liver transplantation in hepatocellular carcinoma". Lo CM Surgery; 2007 Jul; 142(1):119-20. PubMed ID: 17630008 [No Abstract] [Full Text] [Related]
8. Predicting the posttransplant prognosis of patients with hepatocellular carcinoma: what lies beneath alpha-fetoprotein? Giannini EG; Savarino V Liver Transpl; 2013 Oct; 19(10):1166-7. PubMed ID: 23929508 [No Abstract] [Full Text] [Related]
9. Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer. Mailey B; Artinyan A; Khalili J; Denitz J; Sanchez-Luege N; Sun CL; Bhatia S; Nissen N; Colquhoun SD; Kim J Arch Surg; 2011 Jan; 146(1):26-33. PubMed ID: 21242442 [TBL] [Abstract][Full Text] [Related]
10. Should a biopsy precede liver resection or transplantation for presumed hepatocellular carcinoma when the alfa fetoprotein is normal? Shawcross DL; Naoumov N; Pachiadakis I; Mamais C; Williams R; Jalan R; Gillams A; Lees W Transplantation; 2004 Feb; 77(4):637-8. PubMed ID: 15084957 [No Abstract] [Full Text] [Related]
12. Moving past "One size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantation. Mehta N; Yao FY Liver Transpl; 2013 Oct; 19(10):1055-8. PubMed ID: 23959652 [No Abstract] [Full Text] [Related]
13. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma. Shindoh J; Sugawara Y; Nagata R; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Kokudo N Transpl Int; 2014 Apr; 27(4):391-8. PubMed ID: 24472068 [TBL] [Abstract][Full Text] [Related]
14. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297 [TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. De Carlis L; Giacomoni A; Pirotta V; Lauterio A; Slim AO; Sammartino C; Cardillo M; Forti D J Am Coll Surg; 2003 Jun; 196(6):887-97. PubMed ID: 12788425 [TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of small primary liver carcinoma. Li GH; Li JQ; Zhan YQ Chin Med J (Engl); 1986 Oct; 99(10):827-8. PubMed ID: 2433102 [No Abstract] [Full Text] [Related]
17. Liver transplantation should be offered to patients with small solitary hepatocellular carcinoma and a positive serum alpha fetoprotein rather than resection. Graham JA; Melancon JK; Shetty K; Johnson LB Am J Surg; 2013 Apr; 205(4):374-80. PubMed ID: 23395581 [TBL] [Abstract][Full Text] [Related]
18. Contribution of biomarkers and imaging in the management of hepatocellular carcinoma. Fartoux L; Decaens T Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S21-30. PubMed ID: 21742297 [TBL] [Abstract][Full Text] [Related]
19. Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. Bertuzzo VR; Cescon M; Ravaioli M; Grazi GL; Ercolani G; Del Gaudio M; Cucchetti A; D'Errico-Grigioni A; Golfieri R; Pinna AD Transplantation; 2011 Jun; 91(11):1279-85. PubMed ID: 21617590 [TBL] [Abstract][Full Text] [Related]
20. Metastatic Recurrent Hepatocellular Carcinoma Post Liver Transplant With Marked Pretransplant Elevation of Alpha Fetoprotein and No Evidence of Primary Neoplasm. Kumar S Exp Clin Transplant; 2018 Feb; 16(1):99-102. PubMed ID: 26789285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]